Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy

N. Ando, S. Ozawa, Yuukou Kitagawa, H. Takeuchi, M. Kitajima

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The standard modality of the treatment for the patients with T4 esophageal cancer, whose prognosis still remains quite poor, is not established yet. Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemo-radiotherapy has become to be available. During the period from 1992 to 96, 30 patients with the suspected T4 esophageal cancer underwent chemoradiotherapy, which consisted of two courses of CDDP/5-FU with-sequential or concurrent 50-60Gy radiotherapy. Among them eleven patients became to be resectable by means of thoracotomy and laparotomy and pathological CRs were obtained in either primary lesions or lymph nodes. The longest survival term following surgery is 36 months. Three patients died of cancer recurrence including the organ metastasis and one died from pyothorax without cancer due to severe immunosuppression attributable to chemoradiation. Our results warrants further studies of neoadjuvant chemoradiotherapy for the patients with T4 esophageal cancer.

Original languageEnglish
Pages (from-to)767-772
Number of pages6
JournalNippon Geka Gakkai zasshi
Volume98
Issue number9
Publication statusPublished - 1997

Fingerprint

Chemoradiotherapy
Esophageal Neoplasms
Radiotherapy
Pleural Empyema
Thoracotomy
Fluorouracil
Laparotomy
Immunosuppression
Neoplasms
Lymph Nodes
Neoplasm Metastasis
Recurrence
Survival

Cite this

Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy. / Ando, N.; Ozawa, S.; Kitagawa, Yuukou; Takeuchi, H.; Kitajima, M.

In: Nippon Geka Gakkai zasshi, Vol. 98, No. 9, 1997, p. 767-772.

Research output: Contribution to journalArticle

Ando, N. ; Ozawa, S. ; Kitagawa, Yuukou ; Takeuchi, H. ; Kitajima, M. / Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy. In: Nippon Geka Gakkai zasshi. 1997 ; Vol. 98, No. 9. pp. 767-772.
@article{1a57946bbe584efab79ebe2a36f593df,
title = "Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy",
abstract = "The standard modality of the treatment for the patients with T4 esophageal cancer, whose prognosis still remains quite poor, is not established yet. Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemo-radiotherapy has become to be available. During the period from 1992 to 96, 30 patients with the suspected T4 esophageal cancer underwent chemoradiotherapy, which consisted of two courses of CDDP/5-FU with-sequential or concurrent 50-60Gy radiotherapy. Among them eleven patients became to be resectable by means of thoracotomy and laparotomy and pathological CRs were obtained in either primary lesions or lymph nodes. The longest survival term following surgery is 36 months. Three patients died of cancer recurrence including the organ metastasis and one died from pyothorax without cancer due to severe immunosuppression attributable to chemoradiation. Our results warrants further studies of neoadjuvant chemoradiotherapy for the patients with T4 esophageal cancer.",
author = "N. Ando and S. Ozawa and Yuukou Kitagawa and H. Takeuchi and M. Kitajima",
year = "1997",
language = "English",
volume = "98",
pages = "767--772",
journal = "Nihon Geka Gakkai zasshi",
issn = "0301-4894",
publisher = "Nihon Geka Gakkai",
number = "9",

}

TY - JOUR

T1 - Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy

AU - Ando, N.

AU - Ozawa, S.

AU - Kitagawa, Yuukou

AU - Takeuchi, H.

AU - Kitajima, M.

PY - 1997

Y1 - 1997

N2 - The standard modality of the treatment for the patients with T4 esophageal cancer, whose prognosis still remains quite poor, is not established yet. Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemo-radiotherapy has become to be available. During the period from 1992 to 96, 30 patients with the suspected T4 esophageal cancer underwent chemoradiotherapy, which consisted of two courses of CDDP/5-FU with-sequential or concurrent 50-60Gy radiotherapy. Among them eleven patients became to be resectable by means of thoracotomy and laparotomy and pathological CRs were obtained in either primary lesions or lymph nodes. The longest survival term following surgery is 36 months. Three patients died of cancer recurrence including the organ metastasis and one died from pyothorax without cancer due to severe immunosuppression attributable to chemoradiation. Our results warrants further studies of neoadjuvant chemoradiotherapy for the patients with T4 esophageal cancer.

AB - The standard modality of the treatment for the patients with T4 esophageal cancer, whose prognosis still remains quite poor, is not established yet. Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemo-radiotherapy has become to be available. During the period from 1992 to 96, 30 patients with the suspected T4 esophageal cancer underwent chemoradiotherapy, which consisted of two courses of CDDP/5-FU with-sequential or concurrent 50-60Gy radiotherapy. Among them eleven patients became to be resectable by means of thoracotomy and laparotomy and pathological CRs were obtained in either primary lesions or lymph nodes. The longest survival term following surgery is 36 months. Three patients died of cancer recurrence including the organ metastasis and one died from pyothorax without cancer due to severe immunosuppression attributable to chemoradiation. Our results warrants further studies of neoadjuvant chemoradiotherapy for the patients with T4 esophageal cancer.

UR - http://www.scopus.com/inward/record.url?scp=0031216605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031216605&partnerID=8YFLogxK

M3 - Article

C2 - 9370137

AN - SCOPUS:0031216605

VL - 98

SP - 767

EP - 772

JO - Nihon Geka Gakkai zasshi

JF - Nihon Geka Gakkai zasshi

SN - 0301-4894

IS - 9

ER -